ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1
about
Estrogen receptor alpha gene amplification in breast cancer: 25 years of debateHuman C6orf211 encodes Armt1, a protein carboxyl methyltransferase that targets PCNA and is linked to the DNA damage responseGenome-wide association study in east Asians identifies novel susceptibility loci for breast cancerThe Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers.Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population.An integrated network of microRNA and gene expression in ovarian cancer.A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation.C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US LatinasBreast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Association of five single nucleotide polymorphisms at 6q25.1 with breast cancer risk in northwestern Chinabc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analysesCreation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1)Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer.27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.Estrogen receptor β and Liver X receptor β: biology and therapeutic potential in CNS diseases.ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry.Abnormal miRNAs Targeting Chromosome Open Reading Frame Genes were Enriched in Microvesicles Derived from the Circulation of HCC.Association of oestrogen-receptor gene (ESR1) polymorphisms with migraine in the large Norfolk Island pedigree.Breast cancer risk-associated variants at 6q25.1 influence risk of hepatocellular carcinoma in a Chinese population.Computing molecular signatures as optima of a bi-objective function: method and application to prediction in oncogenomics.The Protein Encoded by the CCDC170 Breast Cancer Gene Functions to Organize the Golgi-Microtubule NetworkModel-based clustering with gene ranking using penalized mixtures of heavy-tailed distributions.Single nucleotide polymorphism 6q25.1 rs2046210 and increased risk of breast cancer.
P2860
Q24273274-B61039BA-5B02-423E-9B45-D6AD87F3D947Q24321253-F260F026-DE28-4A4E-ACF8-77006D103809Q28924377-1F238E13-367E-44B0-ADB7-4ACE7D18B4C5Q30978083-FFB3C7BE-2E4A-4BA6-8237-A31C2DC3A7B8Q31082788-AB1055C4-7D26-4D80-AD7F-63476CC980DCQ34034269-5396C776-E123-479B-8B5C-82D9BD04B9B4Q34927615-7D3DBE20-4DDB-4D0B-8EAB-6690FE2EAAFBQ35000812-58D96A9E-C55E-444B-9A67-39AD934787DFQ35477129-E0FFF8B3-20DC-4D85-BA5D-7C2787729F72Q35574894-5A85E429-BA6E-4C9E-BDB0-8B3F53F0ABDCQ35722184-7CD2FE71-0A61-45BE-850C-E6F01773CD78Q35856257-990E3AA0-0AAB-42B0-81B9-E10377CEBDCEQ35940158-49FF6F3A-56E9-4505-BF98-8C3A54C84980Q36057132-72BBD065-F81A-41BC-AF9B-52700218D58EQ36543286-36FE35D8-B164-4351-AD51-31B4DCB3E986Q36581939-72F6D104-5312-438B-96D8-02854B15DE15Q36839777-7E281A02-944E-46E4-9F52-9E474B7A9AD3Q37297706-D8689633-3FE3-4CC6-9374-2B2E97F4D500Q37632218-30855E31-EFD3-4482-8C68-5D130B6E8215Q38198928-104C5E07-DA6A-44E8-A88E-EB89AC356B73Q38403294-6C1DF1DD-F438-4FB3-A8E3-8C4CEC5A195BQ38454208-33DE86DA-DA47-44F7-BAF3-B30F6D68AD64Q39418853-6ABD46EC-41E9-439B-9CF8-4C2E67B8B1BAQ40277965-545C5940-D821-404B-B001-563531125168Q40521338-0F8427D6-C967-4FEB-BE96-EF605FF691DEQ41347639-7BCD480E-24CF-4DFD-B5F7-95C7EE65DAFEQ43688816-EF754575-B564-44AA-BC33-804A20349A38Q44680094-37A506B4-88CB-4A6B-9057-EE70E2A23F4E
P2860
ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
ESR1 is co-expressed with clos ...... susceptibility locus at 6q25.1
@ast
ESR1 is co-expressed with clos ...... susceptibility locus at 6q25.1
@en
ESR1 is co-expressed with clos ...... susceptibility locus at 6q25.1
@en-gb
ESR1 is co-expressed with clos ...... susceptibility locus at 6q25.1
@nl
type
label
ESR1 is co-expressed with clos ...... susceptibility locus at 6q25.1
@ast
ESR1 is co-expressed with clos ...... susceptibility locus at 6q25.1
@en
ESR1 is co-expressed with clos ...... susceptibility locus at 6q25.1
@en-gb
ESR1 is co-expressed with clos ...... susceptibility locus at 6q25.1
@nl
altLabel
ESR1 Is Co-Expressed with Clos ...... Susceptibility Locus at 6q25.1
@en
prefLabel
ESR1 is co-expressed with clos ...... susceptibility locus at 6q25.1
@ast
ESR1 is co-expressed with clos ...... susceptibility locus at 6q25.1
@en
ESR1 is co-expressed with clos ...... susceptibility locus at 6q25.1
@en-gb
ESR1 is co-expressed with clos ...... susceptibility locus at 6q25.1
@nl
P2093
P2860
P50
P1433
P1476
ESR1 is co-expressed with clos ...... usceptibility locus at 6q25.1.
@en
P2093
Helen Anderson
Kally Sidhu
Lesley-Ann Martin
Mitch Dowsett
Suzanne Drury
Zara Ghazoui
P2860
P304
P356
10.1371/JOURNAL.PGEN.1001382
P407
P577
2011-04-28T00:00:00Z